Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RIG-ing an antitumor response

Nature Medicine volume 14, pages 1152–1153 (2008)Cite this article

A small interfering RNA has been engineered to silence an oncogene and activate the immune response simultaneously. The approach shrinks tumors in mice (pages 1256–1263).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A dual-function small RNA.

References

  1. de Fougerolles, A., Vornlocher, H.P., Maraganore, J. & Lieberman, J. Nat. Rev. Drug Discov. 6, 443–453 (2007).

    Article  CAS  Google Scholar 

  2. Kleinman, M.E. et al. Nature 452, 591–597 (2008).

    Article  CAS  Google Scholar 

  3. Sioud, M. Eur. J. Immunol. 36, 1222–1230 (2006).

    Article  CAS  Google Scholar 

  4. Poeck, H. et al. Nat. Med. 14, 1256–1263 (2008).

    Article  CAS  Google Scholar 

  5. Yoneyama, M. et al. Nat. Immunol. 5, 730–737 (2004).

    Article  CAS  Google Scholar 

  6. Kumagai, Y., Takeuchi, O. & Akira, S. J. Infect. Chemother. 14, 86–92 (2008).

    Article  CAS  Google Scholar 

  7. Marques, J.T. et al. Nat. Biotechnol. 24, 559–565 (2006).

    Article  CAS  Google Scholar 

  8. Gjertsen, B.T., Bredholt, T., Anensen, N. & Vintermyr, O.K. Curr. Pharm. Biotechnol. 8, 373–381 (2007).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fabio Petrocca and Judy Lieberman are at the Immune Disease Institute and Department of Pediatrics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts, 02115, USA. lieberman@idi.harvard.edu,

    Fabio Petrocca & Judy Lieberman

Authors
  1. Fabio Petrocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy Lieberman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

J.L. is on the Scientific Advisory Board of Alnylam Pharmaceuticals and Cequent Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petrocca, F., Lieberman, J. RIG-ing an antitumor response. Nat Med 14, 1152–1153 (2008). https://doi.org/10.1038/nm1108-1152

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1108-1152

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing